Stock MATINAS BIOPHARMA HOLDINGS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Matinas BioPharma Holdings Inc Other OTC

Equities

US5768101058

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Matinas BioPharma Holdings Inc
06-24 Matinas Biopharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in Its Oral Mat2203 Compassionate/Expanded Use Access Program CI
06-18 Transcript : Matinas BioPharma Holdings, Inc. - Special Call

Chart calendar Matinas BioPharma Holdings Inc

06c981ee3de8776ac847f4.9TpisyFmyOFYp6ItL6_xV6Aa7FQieAEbQdudJV7wXpo.o3Va8m1X_68vzNtCHZeTBZJUiC10FFgrJYHXdRadauKlcRSCYhOfjmnPkg~e4782e20fd7b414f435caab22bdc490b

Upcoming events on Matinas BioPharma Holdings Inc

06/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
17/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Matinas BioPharma Holdings Inc

18/06/2024 21:00 Analyst Meeting - A.G.P.
10/05/2024 21:15 American Society of Gene & Cell Therapy Meeting
10/05/2024 17:00 American Society of Gene & Cell Therapy Meeting - Poster # 1709
09/05/2024 21:30 Q1 2024 Earnings Call
09/05/2024 21:05 Q1 2024 Earnings Release
27/03/2024 20:30 Q4 2023 Earnings Call
27/03/2024 20:05 Q4 2023 Earnings Release
09/01/2024 19:00 Biotech Showcase
08/11/2023 21:30 Q3 2023 Earnings Call
08/11/2023 21:05 Q3 2023 Earnings Release
01/11/2023 13:00 Annual General Meeting
19/10/2023 16:00 ThinkEquity Conference
12/10/2023 20:30 Dawson James Small Cap Growth Conference
12/10/2023 13:12 IDWeek Conference
10/09/2023 H.C. Wainwright Global Investment Conference
09/08/2023 21:30 Q2 2023 Earnings Call
09/08/2023 21:05 Q2 2023 Earnings Release
06/08/2023 BTIG Virtual Biotechnology Conference
15/05/2023 14:30 JMP Securities Life Sciences Conference
10/05/2023 21:30 Q1 2023 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,09
0,11
-21.42%		0,16
1,12
-85.82%		0,03
0,36
-90.8%		3,19
2,87
11.04%		1,10
1,10
-0.18%
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-18,7
-17,6
-6.34%		-24,0
-24,4
1.74%		-24,5
-24,9
1.65%		-24,3
-24,1
-0.63%		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-18,9
-18,3
-3.47%		-24,2
-23,4
-3.37%		-24,7
-25,6
3.27%		-24,6
-25,8
4.8%		-23,8
-24,1
1.33%
-25,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-17,4
-17,3
-0.35%		-22,4
-21,4
-4.94%		-23,3
-24,2
3.89%		-21,0
-24,1
12.71%		-22,9
-23,8
3.7%
-25,3

Net income
Million USD		Released
Forecast
Spread 		-18,3
-17,7
-3.34%		-23,2
-22,0
-5.84%		-23,7
-24,5
3.31%		-21,0
-24,1
12.71%		-22,9
-23,7
3.25%
-25,3

EPS
USD		Released
Forecast
Spread 		-0,13
-0,12
-5.41%		-0,12
-0,12
-4.35%		-0,11
-0,12
8.33%		-0,10
-0,11
9.09%		-0,11
-0,11
0%
-0,10

Announcement Date09/03/2029/03/2108/03/2215/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		1,06
0,06
1546.01%		1,06
0,85
25.52%		1,06
0,72
47.43%		1,10
0,30
265.33%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBITDA
Million USD		Released
Forecast
Spread 		-7,65
-6,30
-21.48%		-5,84
-6,40
8.76%		-5,37
-5,80
7.36%		-5,39
-5,30
-1.64%		-5,49
-5,80
5.29%


























EBIT
Million USD		Released
Forecast
Spread 		-7,72
-6,71
-15.05%		-5,93
-7,24
18.11%		-5,46
-6,31
13.4%		-5,48
-5,89
7.01%		-5,59
-5,90
5.32%		-6,16
-6,72
8.41%		-6,13
-6,21
1.23%		-5,89
-6,20
5.01%		-5,90
-5,75
-2.64%
-5,98


-6,51


-7,04







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,98
-6,99
14.53%		-5,92
-7,23
18.07%		-5,46
-6,30
13.37%		-3,63
-5,89
38.28%		-5,51
-5,90
6.56%		-6,06
-6,75
10.21%		-6,06
-6,22
2.67%		-5,31
-6,20
14.22%		-5,82
-5,70
-2.18%
-5,96


-6,49


-7,02







Net income
Million USD		Released
Forecast
Spread 		-5,98
-6,99
14.53%		-5,92
-7,23
18.07%		-5,46
-6,30
13.37%		-3,63
-5,89
38.28%		-5,51
-5,90
6.56%		-6,06
-6,72
9.88%		-6,06
-6,17
1.87%		-5,31
-6,10
12.85%		-5,82
-5,70
-2.18%
-5,96


-6,49


-7,02







EPS
USD		Released
Forecast
Spread 		-0,03
-0,03
0%		-0,03
-0,03
7.69%		-0,03
-0,03
0%		-0,02
-0,03
25.01%		-0,03
-0,03
0%		-0,03
-0,03
0%		-0,03
-0,03
0%		-0,03
-0,03
0%		-0,03
-0,03
0%
-0,03


-0,03


-0,03







Announcement Date12/05/2211/08/2202/11/2215/03/2310/05/2309/08/2308/11/2327/03/2409/05/24-----

Upcoming sector events for Matinas BioPharma Holdings Inc

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 EXELIXIS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Matinas BioPharma Holdings Inc

11/07/2024 21:00 NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release
08/07/2024 LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release
07/07/2024 TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release
04/07/2024 PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release
06/06/2024 LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release
06/06/2024 TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release
05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. MTNB Stock
  4. Stock
  5. Calendar Matinas BioPharma Holdings Inc